Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Aman Patel MD

Aman B Patel MD

Robert G. and Jean A. Ojemann Associate Professor, Director of Cerebrovascular and Endovascular Neurosurgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Dr. Patel is current the Robert G. and Jean A. Ojemann Associate Professor of Neurosurgery and Radiology at Harvard Medical School and Director of the Neuroendovascular Program and Cerebrovascular/Endovascular Neurosurgery at Massachusetts General Hospital with clinical interests in cerebrovascular and endovascular neurosurgery with a focus on the treatment of cerebral aneurysms, vascular malformations and stroke. Dr. Patel leads a multi-disciplinary group of neurosurgeons, radiologists and neurologists with a focus on the care of patients with cerebrovascular disease across the specialties of neurosurgery, radiology and neurology.

An expert in the vasculature of the brain and spine, Dr. Patel is a physician can offer both endovascular and open microsurgical options to patients. He specializes in the minimally invasive treatment of brain and spinal disorders using endovascular techniques that are creating new treatment options for a broad range of conditions, replacing long and difficult traditional surgeries with low-risk interventions. When indicated, he also performs open surgery for cerebrovascular disease and general neurosurgery.

Dr. Patel is involved in multiple multi-center studies, NIH and industry sponsored, that investigate treatments related to ischemic stroke, hemorrhagic stroke, new devices and new techniques.